The new expansion for Aptar Pharma’s Congers site (New York, USA) was inaugurated on 20 March by Stephan Tanda, AptarGroup’s president and CEO, Salim Haffar, president of Aptar Pharma, and Alex Theodorakis, president of Aptar Pharma North America.

Aptar Pharma Congers - Courtesy of Aptar Pharma
This newly-expanded, state-of-the-art manufacturing facility will be used to complete premium injectable elastomeric component manufacturing. These new capabilities will better serve Aptar Pharma’s North American pharmaceutical customers.
According to Bas van Buijtenen, president, Injectables Division, Aptar Pharma, this expansion supports growth in three directions. “This investment is continuing our commitment to growing and accelerating our footprint in North America. More significantly, the technology we are introducing will increase our ability to provide world-class manufacturing capabilities to our customers locally,” he said.
“It adds capacity to our network or global manufacturing sites and will be equipped with the latest technologies to meet growing quality requirements,” explained van Buijtenen. “The proximity to our North American customer base improves our service and responsiveness.”
The equipment housed within the expansion includes state-of-the-art clean rooms and integrated best-in-class vision equipment. “Vision equipment will be used to perform 100% of the automatic inspection of all parts during the finishing process to ensure PremiumVision product quality,” added van Buijtenen. “The increased facility space also enables the company to conduct all our finishing operations in the US, including Aptar Pharma’s recently launched PremiumCoat coated stoppers.”
Following on from this event, the company will welcome current and future customers and partners during the Drug, Chemical & Associated Technologies Association (DCAT) Week and Interphex, at booth 1734.
Aptar Pharma is a part of AptarGroup dedicated to the healthcare industry, providing a large range of specialized drug delivery devices, components and services.